Artivion | CRY - 当期純利益

株価
37.04
毎日の変更
-0.82 -2.17%
毎月
-6.49%
毎年
53.18%
Q1 予測
35.91




当期純利益 変化する 日付
Abbott USD 1.78B 132M 2025-12
Accuray USD 2.54M 6.49M 2024-12
AngioDynamics USD -4.41M 6.33M 2025-02
Artivion USD -2.29M 167K 2024-09
AtriCure USD 1.76M 2.02M 2025-12
Baxter International USD -1.13B 1.08B 2025-12
Becton, Dickinson and Co. USD 382M 111M 2025-12
Boston Scientific USD 672M 83M 2025-12
Edwards Lifesciences USD 91.2M 199.9M 2025-12
Inogen USD -5.96M 373K 2024-09
Integra LifeSciences USD -1.7M 3.7M 2025-12
J&J USD 5.12B 36M 2025-12
Mesa Laboratories USD -1.68M 5.1M 2024-12
Orthofix International USD -126M 98.61M 2024-12
Pfizer USD -1.65B 5.19B 2025-12
ResMed USD 392.59M 44.06M 2025-12
Stryker USD 849M 10M 2025-12
Surmodics USD -11.54M 3.99M 2024-09
Tandem Diabetes Care USD -589K 20.58M 2025-12
Teleflex USD -714.33M 305.44M 2025-12
Terumo JPY 32.65B 2.4B 2025-12
Trinity Biotech USD -5.14M 11.82M 2025-09